» Articles » PMID: 31812504

Motor Deficit in the Mouse Ferric Chloride-induced Distal Middle Cerebral Artery Occlusion Model of Stroke

Overview
Journal Behav Brain Res
Date 2019 Dec 9
PMID 31812504
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Ferric chloride-induced distal middle cerebral artery occlusion (MCAO) model of stroke was described in mice several years ago, however it lacked in-depth evaluation of the post-stroke functional outcomes in the animals. In this study, we reproduced the recently developed model and expanded its characterization by thorough evaluation of blood supply, cerebral infarction, and motor function in adult male and female mice up to 14 days after stroke. Our observations indicate near complete interruption of blood flow in the distal MCA shortly after application of 20 % ferric chloride over the artery through a cranial window, which remained occluded for at least 4 h. As expected, infarction of the brain tissue, documented by TTC and hematoxylin stains, was restricted to the cerebral cortex. We also systematically evaluated motor impairment of the animals in this model. For this, a series of studies were carried out in male and female mice up to 14 days after stroke, and motor function was assessed in cylinder and grid-walking tests in blinded manner. Contrary to our expectations, the results of both motor tests indicated minor, transient motor deficit in mice after stroke. Based on these observations, we conclude that the mouse ferric chloride-induced distal MCAO model is likely not suitable for proof-of-concept and preclinical studies where motor function is an important outcome measure.

Citing Articles

Nanoparticles for Thrombolytic Therapy in Ischemic Stroke: A Systematic Review and Meta-Analysis of Preclinical Studies.

Prego-Dominguez J, Laso-Garcia F, Palomar-Alonso N, Perez-Mato M, Lopez-Arias E, Dopico-Lopez A Pharmaceutics. 2025; 17(2).

PMID: 40006575 PMC: 11859612. DOI: 10.3390/pharmaceutics17020208.


The Effects of Cannabinoids on Ischemic Stroke-Associated Neuroinflammation: A Systematic Review.

Alraddadi E, Aljuhani F, Alsamiri G, Hafez S, Alselami G, Almarghalani D J Neuroimmune Pharmacol. 2025; 20(1):12.

PMID: 39899062 PMC: 11790784. DOI: 10.1007/s11481-025-10171-z.


Functional ultrasound imaging of stroke in awake rats.

Brunner C, Montaldo G, Urban A Elife. 2023; 12.

PMID: 37988288 PMC: 10662948. DOI: 10.7554/eLife.88919.


Adenosine receptor A1 enhanced mitochondrial biogenesis and exerted neuroprotection after cerebral ischemia through PGC-1α.

Han W, Zhang E, Tian Y, Wang S, Chen Y Exp Brain Res. 2023; 241(6):1471-1488.

PMID: 37081178 DOI: 10.1007/s00221-023-06613-w.


Translating Animal Models of Ischemic Stroke to the Human Condition.

Matur A, Candelario-Jalil E, Paul S, Karamyan V, Lee J, Pennypacker K Transl Stroke Res. 2022; 14(6):842-853.

PMID: 36125734 DOI: 10.1007/s12975-022-01082-9.


References
1.
Cook D, Nguyen C, Chun H, Llorente I, Chiu A, Machnicki M . Hydrogel-delivered brain-derived neurotrophic factor promotes tissue repair and recovery after stroke. J Cereb Blood Flow Metab. 2016; 37(3):1030-1045. PMC: 5363479. DOI: 10.1177/0271678X16649964. View

2.
Orset C, Macrez R, Young A, Panthou D, Angles-Cano E, Maubert E . Mouse model of in situ thromboembolic stroke and reperfusion. Stroke. 2007; 38(10):2771-8. DOI: 10.1161/STROKEAHA.107.487520. View

3.
Casals J, Pieri N, Feitosa M, Ercolin A, Roballo K, Barreto R . The use of animal models for stroke research: a review. Comp Med. 2012; 61(4):305-13. PMC: 3155396. View

4.
Pautus S, Alami M, Adam F, Bernadat G, Lawrence D, de Carvalho A . Characterization of the Annonaceous acetogenin, annonacinone, a natural product inhibitor of plasminogen activator inhibitor-1. Sci Rep. 2016; 6:36462. PMC: 5120274. DOI: 10.1038/srep36462. View

5.
Freret T, Bouet V, Leconte C, Roussel S, Chazalviel L, Divoux D . Behavioral deficits after distal focal cerebral ischemia in mice: Usefulness of adhesive removal test. Behav Neurosci. 2009; 123(1):224-30. DOI: 10.1037/a0014157. View